APPROACH TO ASTHMA AND MODALITIES OF MANAGEMENT
Main Article Content
Keywords
Asthma, chronic respiratory disease, diagnosis, treatment
Abstract
Background: Asthma is a chronic respiratory condition characterized by inflammation in the airways, leading to recurring episodes of wheezing, breathlessness, chest tightness, and coughing. These symptoms often occur due to the airways' heightened sensitivity to various triggers, resulting in temporary narrowing and obstruction. Asthma can affect individuals of all ages, and its severity can vary from mild to severe.
Aim: The literature review aims to overview the latest update on the approach to asthma and various management modalities.
Methods: The present study is a comprehensive research of PUBMED from 2000 to 2023.
Conclusion: Despite being prevalent in both children and adults, adults tend to have higher morbidity and mortality rates. Recent research suggests a possible link between sex hormones and asthma development. The disease's prevalence has increased globally, likely due to environmental factors. Asthma's pathophysiology involves complex interactions between immune cells and molecules, leading to airway inflammation, hyperresponsiveness, obstruction, and remodeling. Symptoms include wheezing, coughing, chest tightness, and breathlessness, which vary in severity and frequency. Asthma can manifest in different phenotypes, classified based on inflammatory cell profiles and clinical features. Diagnosis relies on clinical evaluation, lung function tests, and objective measurements. Treatment aims to control symptoms and prevent exacerbations using inhaled corticosteroids, long-acting β2-agonists, and combination inhalers.
References
2. Dharmage SC, Perret JL, Custovic A: Asthma epidemiology in children and adults. Frontiers in pediatrics. 2019, 7:246.
3. Shinde V, Wankhede P, Vyawahare N: Asthma: Cells involved in the pathophysiology of asthma. The Journal of Association of Chest Physicians. 2023, 11:10-18.
4. Holgate ST: 7 - Asthma. Allergy Essentials (Second Edition). O'Hehir RE, Holgate ST, Khurana Hershey GK, Sheikh A (eds): Elsevier, Philadelphia; 2022. 123-169. https://doi.org/10.1016/B97 8-0-323-80912-2.00007-X
5. Feng Y, Liu X, Wang Y, Du R, Mao H: Delineating asthma according to inflammation phenotypes with a focus on paucigranulocytic asthma. Chinese Medical Journal. 2023, 136.
6. Matabuena M, Salgado FJ, Nieto-Fontarigo JJ, et al.: Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis. Archivos de Bronconeumología. 2023, 59:223-231. https://doi.org/10.1016/j.arbres.2023.01.007
7. McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ: Diagnosis and Management of Asthma in Adults: A Review. Jama. 2017, 318:279-290. 10.1001/jama.2017.8372
8. Zhan J, Chen W, Cheng L, Wang Q, Han F, Cui Y: Diagnosis of Asthma Based on Routine Blood Biomarkers Using Machine Learning. Computational Intelligence and Neuroscience. 2020, 2020:1-8. 10.1155/2020/8841002
9. Saglani S, Menzie-Gow AN: Approaches to Asthma Diagnosis in Children and Adults. Frontiers in Pediatrics. 2019, 7. 10.3389/fped.2019.00148
10. Ukena D, Fishman L, Niebling WB: Bronchial asthma: diagnosis and long-term treatment in adults. Dtsch Arztebl Int. 2008, 105:385-394. 10.3238/arztebl.2008.0385
11. Hashmi MF, Tariq M, Cataletto ME, Hoover EL: Asthma (Nursing). 2021.
12. Cazzola M, Page CP, Matera MG, Rogliani P, Hanania NA: Revisiting asthma pharmacotherapy: where do we stand and where do we want to go? European Respiratory Journal. 2023, 62:2300700. 10.1183/13993003.00700-2023
13. Amison RT, Page CP: Novel pharmacological therapies for the treatment of bronchial asthma. Minerva Medica. 2021, 113:31-50.
14. Pera T, Loblundo C, Penn RB: 4.34 - Pharmacological Management of Asthma and COPD. Comprehensive Pharmacology. Kenakin T (ed): Elsevier, Oxford; 2022. 762-802. https://doi.org/10.1016/B978-0-12-820472-6.00095-5
15. Cazzola M, Rogliani P, Naviglio S, Calzetta L, Matera MG: An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert Opinion on Pharmacotherapy. 2022, 23:1205-1216. 10.1080/14656566.2022.2083955
16. Mehrabi Nasab D, Taheri A, Athari SS: Design and Fabrication of Gold Nanoparticles for Anti-Asthma Drug Delivery. Archives of Medical Laboratory Sciences. 2020, 6:1-7 (e4). 10.22037/amls.v6.32580
17. Moermans C, Graff S, Laurie M, et al.: Effects of probiotics in uncontrolled asthma. Eur Respiratory Soc; 2022.
18. Evans DJ, Cullinan P, Geddes DM, Walters EH, Milan SJ, Jones P: Gold as an oral corticosteroid sparing agent in stable asthma. Cochrane Database of Systematic Reviews. 2000. 10.1002/14651858.CD002985
19. Tao S, Fan Q, Hariharan VS, Zhi H: Effectiveness of nursing interventions for management of children with bronchial asthma: A systematic review and meta-analysis. International Journal of Nursing Practice. 2023, 29:e13139. https://doi.org/10.1111/ijn.13139
20. Bernstein CK, Tolomeo C: How Care Coordinators and Other Nursing Professionals Can Help Optimize Care of Asthma in Older Adults. Treatment of Asthma in Older Adults: A Comprehensive, Evidence-Based Guide. Epstein TEG, Nyenhuis SM (eds): Springer International Publishing, Cham; 2019. 101-111. 10.1007/978-3-030-20554-6_9
21. Gruffydd-Jones K, Hansen K: Working for Better Asthma Control: How Can We Improve the Dialogue Between Patients and Healthcare Professionals? Advances in Therapy. 2020, 37:1-9. 10.1007/s12325-019-01131-0